Woodline Partners’s CERo Therapeutics CERO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-150	Closed	-$3.01M	–	833
2022 Q2	$3.01M	Buy	150 +137	+1,054%	+$2.75M	0.05%	332
2022 Q1	$250K	Hold	13	–	–	﹤0.01%	538
2021 Q4	$248K	Buy	+13	New	+$248K	﹤0.01%	580